Hospitalized COVID-19 patients with prolonged fever showed more pronounced inflammatory response and were more likely to require ICU admission than cases with saddleback fever or with fever lasting ≤7 days, a Singapore study reveals.
As high as 40 percent of the healthcare workers (HCWs) infected with COVID-19 were asymptomatic, raising concerns on silent transmission in the healthcare settings, according to a systematic review and meta-analysis released during ECCVID 2020.
Regular, low-dose, oral sustained-release morphine improved the health status of patients with moderate-to-very-severe chronic breathlessness due to chronic obstructive pulmonary disease (COPD), the MORDYC* trial has shown, validating its palliative role for chronic breathlessness.
Not only do asymptomatic COVID-19 carriers have viral loads that are similar to symptomatic patients, they could remain asymptomatic for a prolonged period of median 24 days from diagnosis, reveals a study.
Shortness of breath, or dyspnoea after some exertion, can sometimes be associated with reduced fitness and ageing. However, GPs should not overlook the possibility that the symptom could be a warning sign of heart and lung diseases, experts caution.
Patients with COVID-19 who experience an ischaemic stroke may have worse outcomes, including greater stroke severity and mortality risk, than those without COVID-19, findings from the Global COVID-19 Stroke Registry showed.
A 4-week course of amoxicillin-clavulanate in children with protracted bacterial bronchitis (PBB) does not improve cough resolution rates compared with a 2-week course, according to a study from Australia. However, the longer course may significantly extend time to first cough exacerbation.